+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Aseptic Sampling Market - Growth, Trends, and Forecast (2020 - 2025)

  • ID: 4896177
  • Report
  • January 2020
  • Region: Global
  • 112 pages
  • Mordor Intelligence
UP TO OFF
until Mar 31st 2020
1 of 4

FEATURED COMPANIES

  • GEA Group
  • Gemu Group
  • Gore & Associates
  • Keofitt A/S
  • Lonza
  • Merck KGaA
  • MORE
Market Overview

The aseptic sampling market studied was anticipated to grow with a CAGR of nearly 13.6% during the forecast period. The major factors attributing to the growth of the aseptic sampling market are the rise in the demand for biopharmaceuticals which resulted in the increased adoption of single-use aseptic sampling products. For instance, according to the Centers for Disease Control and Prevention, in 2018, the United States spent approximately USD 3.65 trillion on national health care. As a result of the increase in government expenditure for healthcare, government regulations to ensure drug safety, R&D activities in the segment increase globally, fueling the aseptic sampling market.

Scope of the Report

Aseptic sampling is a sterile method of collecting a sample that is implemented during biopharmaceutical processes, to avoid probable contaminations or alterations, while sampling the drug for research and analysis.

Key Market Trends

Manual aseptic sampling segment by Type of Analysis is Expected to Hold the Major Market Share in the aseptic sampling Market
  • In the aseptic sampling market, the manual aseptic sampling segment is anticipated to account for the highest market share of the aseptic sampling market. This is mainly due to its wide range of applications in pharmaceutical and biotechnology companies with ease of use.
  • Moreover, manufacturers are reluctant to shift to automatic sampling. The reluctance is due to the high cost of investments on equipment as well as maintenance costs, and the necessity of proper staff training to program the automatic sampler. As a result, the manual aseptic sampling segment is dominating the market globally.
  • Based on the technique, the off-line segment is expected to account for the significant share in the aseptic sampling market as the off-line sampling technique is a widely accepted method by the industries and research institutes from years, the segment fuels the growth of the market.
Europe Dominates the Market and Expected to do Same in the Forecast Period.

Europe is expected to dominate the overall aseptic sampling market, throughout the forecast period. This dominance is mainly due to the biopharmaceutical companies in Europe have tremendous government support to research and bring forth newer drugs with better efficacy than conventional drugs.
And, North America holds the second-largest revenue share of the aseptic sampling market and expected to do the same in the forecast period. Also, the increase in government expenditure for the healthcare sector, early product launches and stringent government regulations regarding the safety and quality of various drugs will drive the North American aseptic sampling market.
The Asia Pacific aseptic sampling market is anticipated to show the highest growth rate throughout the forecast period, owing to large-scale investments made by the key players. Furthermore, the increasing research activities in developing countries, such as China and India will give rise to advanced technological equipment and sampling techniques which boost the market growth in the region. Also, the growing product awareness and well-established pharmaceutical companies in India have resulted in the promotion of research activities and the launch of new pharmaceutical products.

Competitive Landscape

The aseptic sampling market is moderately competitive and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some prominent players are acquiring the products, entering into partnerships with the other companies to consolidate their market positions across the globe and while others are distributing products. Some of the companies which are currently dominating the market are Merck KGaA, Sartorius Stedim Biotech, Keofitt A/S, Saint Gobain, and GEA Group.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format.
  • Report customization as per the client's requirements.
  • 3 months of analyst support.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • GEA Group
  • Gemu Group
  • Gore & Associates
  • Keofitt A/S
  • Lonza
  • Merck KGaA
  • MORE
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Stringent Government Regulations for Ensuring Drug Safety
4.2.2 Increasing Demand for Biopharmaceuticals to Eliminate the Risk of Contamination
4.3 Market Restraints
4.3.1 Issues Related to Leachable and Extractables With the Plastic Materials in Sampling Procedure
4.3.2 Unknown Impurities Generated During the Biopharmaceutical Processes Due to Employment of High Temperatures
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 Type of Analysis
5.1.1 Manual Aseptic Sampling
5.1.1.1 Bags
5.1.1.2 Syringes
5.1.1.3 Bottles
5.1.1.4 Accessories
5.1.2 Automated Aseptic Sampling
5.2 Technique
5.2.1 Off-Line Sampling
5.2.2 At-Line Sampling
5.2.3 On-Line Sampling
5.3 Application
5.3.1 Upstream Process
5.3.2 Downstream Process
5.4 End-User
5.4.1 Biotechnology and Pharmaceutical Manufacturers
5.4.2 Contract Research and Manufacturing Organizations
5.4.3 Research and Development Departments
5.4.4 Others
5.5 Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 Germany
5.5.2.2 United Kingdom
5.5.2.3 France
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia Pacific
5.5.3.1 China
5.5.3.2 Japan
5.5.3.3 India
5.5.3.4 Australia
5.5.3.5 South Korea
5.5.3.6 Rest of Asia-Pacific
5.5.4 Middle East and Africa
5.5.4.1 GCC
5.5.4.2 South Africa
5.5.4.3 Rest of Middle East and Africa
5.5.5 South America
5.5.5.1 Brazil
5.5.5.2 Argentina
5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Merck KGaA
6.1.2 Sartorius Stedim Biotech
6.1.3 Keofitt A/S
6.1.4 Saint Gobain
6.1.5 GEA Group
6.1.6 Qualitru Sampling Systems
6.1.7 Thermo Fisher Scientific
6.1.8 Gemu Group
6.1.9 Gore & Associates
6.1.10 Lonza

7 MARKET OPPORTUNITIES AND FUTURE TRENDS
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Merck KGaA
  • Sartorius Stedim Biotech
  • Keofitt A/S
  • Saint Gobain
  • GEA Group
  • Qualitru Sampling Systems
  • Thermo Fisher Scientific
  • Gemu Group
  • Gore & Associates
  • Lonza
Note: Product cover images may vary from those shown
Adroll
adroll